Literature DB >> 9184653

Central nervous system cytokine mRNA expression following Theiler's murine encephalomyelitis virus infection.

S Sato1, S L Reiner, M A Jensen, R P Roos.   

Abstract

DA strain of Theiler's murine encephalomyelitis virus (TMEV) produces a biphasic disease with an initial self-limited acute gray matter polioencephalomyelitis in all strains of mice followed by, in the case of certain susceptible strains of mice, a chronic inflammatory demyelination of the spinal cord with a persistent virus infection. A pathogenic role for T-helper 1 (Th1) cells during the demyelinating phase of disease has been proposed. We characterized the cytokine mRNA expression in the brain and spinal cord of susceptible and resistant strains of mice during the early encephalomyelitic disease and the late demyelination, using a semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR) assay. At the time of the encephalomyelitis, both resistant and susceptible mice expressed proinflammatory cytokine mRNAs followed by T-cell derived mRNAs; susceptible mice expressed more IL-12 p40 mRNA than resistant mice. During this early disease, there was no significant difference in Th1 cytokine mRNA expression in the brain and spinal cord among the four strains and relatively little Th2 type cytokine upregulation above levels seen in mock-infected controls. During the late demyelinating disease, susceptible but not resistant mice had evidence of viral genome and a continuous expression of Th1 type cytokine mRNAs. The expression of Th2 cytokine mRNAs varied among the different strains and did not correlate with susceptibility or resistance. The results indicate the complexity of cytokine mRNA expression following TMEV infection and the dependence of the expression on disease pathology, the time following infection and the genetics of the host.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9184653     DOI: 10.1016/s0165-5728(97)00059-3

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  13 in total

1.  Infection with Theiler's murine encephalomyelitis virus directly induces proinflammatory cytokines in primary astrocytes via NF-kappaB activation: potential role for the initiation of demyelinating disease.

Authors:  JoAnn P Palma; Daeho Kwon; Neil A Clipstone; Byung S Kim
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

2.  Inflammation in neuroviral diseases.

Authors:  Pascale Giraudon; Arlette Bernard
Journal:  J Neural Transm (Vienna)       Date:  2010-08       Impact factor: 3.575

3.  Social disruption induced priming of CNS inflammatory response to Theiler's virus is dependent upon stress induced IL-6 release.

Authors:  E G Vichaya; E E Young; M A Frazier; J L Cook; C J Welsh; M W Meagher
Journal:  J Neuroimmunol       Date:  2011-10-13       Impact factor: 3.478

4.  Interleukin-6 as a mechanism for the adverse effects of social stress on acute Theiler's virus infection.

Authors:  Mary W Meagher; Robin R Johnson; Erin E Young; Elisabeth G Vichaya; Shannon Lunt; Elizabeth A Hardin; Marilyn A Connor; C Jane R Welsh
Journal:  Brain Behav Immun       Date:  2007-06-25       Impact factor: 7.217

5.  Transition from acute to persistent Theiler's virus infection requires active viral replication that drives proinflammatory cytokine expression and chronic demyelinating disease.

Authors:  Mark Trottier; Brian P Schlitt; Aisha Y Kung; Howard L Lipton
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

6.  Sensitization to the effects of tumor necrosis factor-alpha: neuroendocrine, central monoamine, and behavioral variations.

Authors:  S Hayley; K Brebner; S Lacosta; Z Merali; H Anisman
Journal:  J Neurosci       Date:  1999-07-01       Impact factor: 6.167

7.  Differential virus replication, cytokine production, and antigen-presenting function by microglia from susceptible and resistant mice infected with Theiler's virus.

Authors:  Young-Hee Jin; Mani Mohindru; Min H Kang; Alyson C Fuller; Bongsu Kang; Daniel Gallo; Byung S Kim
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

Review 8.  Theiler's virus infection: a model for multiple sclerosis.

Authors:  Emilia L Oleszak; J Robert Chang; Herman Friedman; Christos D Katsetos; Chris D Platsoucas
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

9.  A protein critical for a Theiler's virus-induced immune system-mediated demyelinating disease has a cell type-specific antiapoptotic effect and a key role in virus persistence.

Authors:  G D Ghadge; L Ma; S Sato; J Kim; R P Roos
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

10.  The immune response in the CNS in Theiler's virus induced demyelinating disease switches from an early adaptive response to a chronic innate-like response.

Authors:  Francesca Gilli; Libin Li; Andrew R Pachner
Journal:  J Neurovirol       Date:  2015-08-11       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.